34,033 Shares in CVS Health Co. (NYSE:CVS) Bought by Kempner Capital Management Inc.

Kempner Capital Management Inc. bought a new position in shares of CVS Health Co. (NYSE:CVS - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 34,033 shares of the pharmacy operator's stock, valued at approximately $2,140,000.

Other large investors also recently added to or reduced their stakes in the company. Livelsberger Financial Advisory purchased a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Crewe Advisors LLC purchased a new position in CVS Health during the 1st quarter worth approximately $40,000. Retirement Group LLC increased its position in CVS Health by 54.3% during the first quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator's stock worth $41,000 after buying an additional 182 shares during the period. Kathleen S. Wright Associates Inc. purchased a new stake in CVS Health in the third quarter valued at approximately $33,000. Finally, First Community Trust NA grew its position in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock worth $33,000 after acquiring an additional 302 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CVS has been the subject of a number of recent research reports. Cantor Fitzgerald reiterated a "neutral" rating and set a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. TD Cowen upgraded shares of CVS Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $59.00 to $85.00 in a research note on Friday, October 4th. Wells Fargo & Company upped their price objective on CVS Health from $60.00 to $61.00 and gave the company an "equal weight" rating in a research note on Monday, August 12th. Deutsche Bank Aktiengesellschaft lowered their target price on CVS Health from $64.00 to $63.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. Finally, Truist Financial upped their price target on CVS Health from $66.00 to $76.00 and gave the stock a "buy" rating in a research note on Friday, October 11th. Nine analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $75.26.

CVS Health Price Performance

NYSE:CVS traded down $1.32 during trading hours on Tuesday, hitting $56.85. 14,539,533 shares of the stock traded hands, compared to its average volume of 11,255,983. The company has a market cap of $71.37 billion, a price-to-earnings ratio of 9.99, a price-to-earnings-growth ratio of 0.93 and a beta of 0.54. The stock has a 50 day moving average price of $59.87 and a 200 day moving average price of $60.19. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts' consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health's revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.21 earnings per share. Sell-side analysts forecast that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.68%. The ex-dividend date is Monday, October 21st. CVS Health's payout ratio is currently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.